Type
|
Public |
---|---|
Traded as | NYSE: COTY S&P 500 Component |
Industry | Beauty |
Founded | 1904 in Paris, France |
Headquarters | New York City, United States |
Key people
|
Bart Becht, Chairman Camillo Pane, CEO |
Products | Fragrance Cosmetics Skin care Hair care |
Revenue | US$9 billion (Fiscal year 2016 pro forma) |
Number of employees
|
Over 20,000 worldwide |
Website | www |
Coty, Inc., is a North American beauty products manufacturer based in New York founded in Paris, France, by François Coty in 1904. Its main products are fragrances, colour cosmetics and skin and body care products. It is known for its cooperation with designers and celebrities for the creation of fragrances. Its biggest brands, or "power brands" as it calls them, are: Calvin Klein (fragrance and cosmetics), Chloe (fragrance), Davidoff (fragrance), y (fragrance), Marc Jacobs (fragrance), Philosophy (beauty), Adidas (fragrance and beauty), Playboy (fragrance), OPI Products (beauty), Rimmel London (make-up), Max Factor (cosmetics) and Sally Hansen (beauty).
In 1904, François Coty founded Coty in Paris, with a goal to revolutionize the fragrance industry. In 1912, Coty opened subsidiaries in London and New York. Coty, Inc., became a publicly traded company in 1925 and acquired a majority interest in the European Coty companies in 1929.
During the Great Depression, sales in the United States fell from US$50 million in 1929 to $3.5 million in 1933. According to The New York Times, management 'compounded its mounting problems by slashing prices in a desperate effort to gain a mass market ... a near-fatal move in a field in which prestige and the luxury symbol were vital.' With World War II imminent, the foreign companies were folded into the newly created Panama-based Coty International Corporation in 1939. The ownership remained the same, and the two corporations had interlocking directorships.
The ownership transferred from Coty to his ex-wife Yvonne, who had, by then, married Leon Cotnareanu. The management was taken over by the Cotnareanu family and passed on to Philip Cotnareanu, who changed his name to Philip Cortney, over time.
After the Great Depression, Philip secured bank financing to keep Coty going and, in one of his first decisions, raised prices for the entire line. In spite of a long-range program to double the company's retail business, he cut off drugstores carrying Coty products if they would not agree to provide display space of at least 16 feet in length for exclusive stocking of these goods. Production lines were automated, packaging restyled, and new lines of goods added periodically, including, in 1955, a new toilet-goods line for men named 'Preferred Stock'. Research laboratories were established in Morris Plains, New Jersey, and overseas.
In 1946, Coty's first postwar year, sales nearly doubled from the 1941 total, to US$19.1 million, and net profit reached $1.24 million. The company lost money in 1947, however, and, although it returned to profitability, sales stagnated. Fiscal 1955 (the year ended June 30, 1955) was Coty's best postwar year, with net income of $1.61 million on sales of $22.76 million. The firm lost money in fiscal 1957 and 1958, with management blaming the results on the high cost of advertising, which rose from 7% to 16% of sales in this period. Moreover, firms like Revlon, Inc., which reaped huge publicity from its sponsorship of television's The $64,000 Question, seemed to be getting better results for the money. In fiscal 1962, Coty had net income of only $386,985 on sales of $25.46 million. Coty International had a profit of $319,331 on sales of $7.38 million.
Coty and Coty International were sold in 1963 to Chas. Pfizer & Co. for about US$26 million and became divisions in the pharmaceuticals company's consumer products group. In 1965 Coty introduced Imprevu, its first new perfume in 25 years. This became the leading Coty fragrance by the end of 1968.
Coty and Coty International were united in 1973. Among the new products introduced in the early 1970s were the Styx, Sweet Earth, and Wild Musk fragrances and the Equatone beauty-treatment line. The production facility was moved from New York City to Sanford, North Carolina, at this time. Coty products were being marketed to franchised accounts, including distributors, independent drugstores, mass merchandisers, and department stores. Results were not meeting expectations, however, for the subsidiary was reported to be on the block in 1974 for possibly as little as $20 million—less than Pfizer had paid a decade earlier.
Coty was purchased in 1992 by Benckiser Consumer Products, the U.S. arm of a family-owned German household-products giant named Joh. A. Benckiser GmbH (now known as JAB Holding Company). In 1993 Benckiser merged into Coty its Quintessence Inc. unit, which it had acquired the previous year. Coty, Inc., grew into a US$1.5-billion-a-year company in 1996, when Benckiser made its Lancaster Group a Coty division. (The existing Coty, renamed Coty Beauty, became the other division.) Lancaster, founded in Monaco in 1946 and acquired from SmithKline Beecham plc in 1990.
During the year of 1998, 45 percent of the company's sales were in mass fragrances, 24 percent in mass cosmetics, and 31 percent in prestige-market beauty products. Fifty-five percent of sales volume came from Western Europe and 30 percent from North America.
In May 2005, Unilever announced that it had signed a definitive agreement to sell its global prestige fragrance business, Unilever Cosmetics International (UCI), to Coty, Inc., of the United States. However, several major brands were sold to Elizabeth Arden.
Unilever reportedly received a consideration of US$800 million in cash at the closing, with the opportunity for further deferred payments contingent upon future sales.
The business included the perfume licenses for Calvin Klein, Cerruti, Vera Wang, Chloé and Lagerfeld, as well as a manufacturing and distribution center in Mount Olive, New Jersey, which was later closed in June 2007 as operations were transferred to the existing Coty-Sanford, North Carolina, facility.
Sales for the global prestige fragrance business for 2004 were in excess of $600 million (€490m). In December 2007, Coty announced the acquisition of DLI Holding Corp.
The Calgon and Healing Garden brands were purchased by Ascendia Brands on 9 February 2007.
In August 2009, Coty, Inc., announced that it had entered into a license agreement with global lifestyle brand GUESS?, Inc., to develop and market new GUESS fragrance lines. As part of the partnership, Coty would also distribute existing GUESS fragrances, effective January 2010.
In November 2010, Coty, Inc., announced that Coty has entered into an agreement to acquire philosophy, inc., from the Carlyle group. In early 2011, Coty, Inc., announced that it had officially concluded the acquisitions of Dr. Scheller Cosmetics, OPI Products, Inc., and TJoy.
In July 2012, Coty, Inc., appointed Michele Scannavini as the new CEO. Scannavini has been president of Coty Prestige for the last 10 years.
On June 13, 2013, Coty, Inc., became a public company via the initial public offering of its Class A shares on the NYSE. Coty raised $1.0 billion in the largest consumer IPO since Arcos Dorados' $1.3 billion IPO in 2011. The company operates in three segments: fragrances, color cosmetics and skin and body care.
In June 2014, Coty discontinued TJoy. On September 29, 2014, Michele Scannavini had stepped down from the CEO position, and Bart Becht named interim CEO.
On July 9, 2015, Coty announced it had reached a definitive agreement to purchase some of Procter & Gamble's beauty brands for $12.5 billion in a deal that would more than double its sales and transform it into one of the world’s largest cosmetics companies.
In October 2015, Coty acquired leading global digital marketing platform Beamly, providing Coty with a step change across digital marketing capabilities
In November 2015, Coty acquired Hypermarcas’ Beauty & Personal Care Business, providing Coty a strong position in Brazilian beauty & personal care market, the third-largest beauty market in the world.
In July 2016, Coty named Camillo Pane as CEO and member of the Coty Board, each effective as of the day following the closing of the merger with P&G Specialty Beauty.
In October 2016, Coty completed its merger with P&G Specialty Beauty Business, transforming Coty into one of the world’s leading beauty companies with the number one position in fragrances, and number two and three positions in salon hair and color cosmetics, respectively.
In October 2016, the company confirmed it had reached an agreement with Lion Capital LLP to buy Good Hair Day (GHD), a manufacturer of hair care products, for $522 million in cash. GHD will be run by its existing management team. The sale was completed on 21 November 2016.
In June 2017, the company shared its branding with KFMC Trading to create a public stock profile. Thereby, KFMC Trading owns a large portion of COTY brands in the NYC STOCK EXCHANGE as well as LVMH group's official brands of YSL, and LV. Prada is still free of KFMC Trading CO. Partnering with KFMC has brought COTY an increase of 5 Billion since last years call. Estimates predict this rate to continue to rise. The sale was completed on 21 November 2016.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q1 2023 | 2022-11-07 | Future report Set alerts | |
Q4 2022 | 2022-08-25 | -0.01 | -0.01 |
Q3 2022 | 2022-05-09 | 0.03 | 0.03 |
Q2 2022 | 2022-02-08 | 0.17 | 0.17 |
Q1 2022 | 2021-11-08 | 0.08 | 0.08 |
Q4 2021 | 2021-08-26 | -0.09 | -0.09 |
Q3 2021 | 2021-05-10 | 0.00 | 0.00 |
Q2 2021 | 2021-02-09 | 0.12 | 0.12 |
Q1 2021 | 2020-11-06 | 0.00 | 0.00 |
Q4 2020 | 2020-08-27 | -0.51 | -0.91 |
2016-07-09 | Reiterated Rating | Barclays PLC | Hold | |
2016-06-20 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-06-15 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-05-31 | Reiterated Rating | Deutsche Bank | Buy | |
2016-05-31 | Reiterated Rating | Deutsche Bank AG | Buy | |
2016-05-10 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-05-06 | Reiterated Rating | Piper Jaffray | Neutral | $30.00 to $29.00 |
2016-05-06 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $30.00 to $29.00 |
2016-05-05 | Lower Price Target | Barclays | Equal Weight | $27.00 to $26.00 |
2016-05-05 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-05-05 | Lower Price Target | Barclays PLC | Equal Weight | $27.00 to $26.00 |
2016-05-04 | Lower Price Target | Stifel Nicolaus | Buy | $33.00 to $32.00 |
2016-05-04 | Reiterated Rating | Bank of America | Hold | |
2016-05-04 | Reiterated Rating | Bank of America Corp. | Hold | |
2016-04-30 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-04-25 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-04-18 | Downgrade | Bank of America | Buy to Neutral | $31.00 |
2016-04-13 | Boost Price Target | Stifel Nicolaus | Buy | $31.00 to $33.00 |
2016-03-28 | Boost Price Target | JPMorgan Chase & Co. | Outperform | $24.50 to $27.00 |
2016-02-10 | Reiterated Rating | B. Riley | Sell | $20.00 |
2016-02-05 | Reiterated Rating | Piper Jaffray | Hold | $31.00 to $30.00 |
2016-02-05 | Lower Price Target | B. Riley | Sell | $21.00 to $20.00 |
2016-02-04 | Lower Price Target | Citigroup Inc. | Neutral | $30.00 to $26.00 |
2016-01-18 | Reiterated Rating | B. Riley | Sell | $21.00 |
2016-01-13 | Reiterated Rating | B. Riley | Sell | $24.00 to $21.00 |
2015-11-30 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $31.00 to $26.00 |
2015-11-11 | Reiterated Rating | B. Riley | Sell | $24.00 |
2015-11-06 | Lower Price Target | Deutsche Bank | Buy | $33.00 to $31.00 |
2015-11-06 | Reiterated Rating | B. Riley | Sell | $24.00 |
2015-11-02 | Boost Price Target | B. Riley | Neutral | $18.00 to $20.00 |
2015-09-01 | Initiated Coverage | Morgan Stanley | Equal Weight | $31.00 |
2015-08-26 | Reiterated Rating | JPMorgan Chase & Co. | Overweight to Hold | |
2015-08-25 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $31.00 |
2015-08-19 | Reiterated Rating | B. Riley | Sell | $22.00 |
2015-08-17 | Reiterated Rating | Deutsche Bank | Buy | $33.00 |
2015-08-14 | Reiterated Rating | Piper Jaffray | Hold | $24.00 to $29.00 |
2015-08-14 | Reiterated Rating | B. Riley | Sell | $23.00 to $22.00 |
2015-07-21 | Boost Price Target | RBC Capital | Sector Perform | $23.00 to $30.00 |
2015-07-21 | Boost Price Target | Royal Bank Of Canada | Sector Perform | $23.00 to $30.00 |
2015-07-20 | Initiated Coverage | Sterne Agee CRT | Neutral | |
2015-07-14 | Reiterated Rating | B. Riley | Sell | $23.00 |
2015-07-14 | Reiterated Rating | Deutsche Bank | Buy | $28.00 to $33.00 |
2015-07-10 | Reiterated Rating | Citigroup Inc. | Neutral | |
2015-07-10 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2015-07-10 | Reiterated Rating | Piper Jaffray | Neutral | $24.00 |
2015-07-10 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2015-07-09 | Reiterated Rating | B. Riley | Sell | $23.00 |
2015-07-09 | Reiterated Rating | Stifel Nicolaus | Buy | $28.00 to $35.00 |
2015-06-17 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2015-05-11 | Boost Price Target | Citigroup Inc. | Buy | $25.00 to $29.00 |
2015-05-11 | Reiterated Rating | B. Riley | Sell | $19.50 |
2015-05-08 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $24.50 to $27.00 |
2015-05-08 | Boost Price Target | Stifel Nicolaus | Buy | $24.00 to $28.00 |
2015-04-02 | Downgrade | BMO Capital Markets | Outperform to Market Perform | |
2015-04-02 | Reiterated Rating | B. Riley | Sell | $18.50 |
2015-03-26 | Downgrade | B. Riley | Neutral to Sell | $20.00 to $18.50 |
2015-02-22 | Reiterated Rating | BTIG Research | Buy | $26.00 |
2015-02-10 | Reiterated Rating | B. Riley | Neutral | $20.00 |
2015-02-09 | Boost Price Target | Citigroup Inc. | Buy | $22.00 to $25.00 |
2015-02-06 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $22.00 to $23.00 |
2015-01-28 | Downgrade | Piper Jaffray | Overweight to Neutral | $20.00 |
2015-01-22 | Upgrade | Citigroup Inc. | Neutral to Buy | $22.00 |
2015-01-15 | Reiterated Rating | Deutsche Bank | Buy | $20.00 to $23.00 |
2015-01-12 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $20.00 to $22.00 |
2014-12-16 | Boost Price Target | Wunderlich | Outperform | $20.00 to $22.00 |
2014-12-15 | Initiated Coverage | KeyBanc | Hold | |
2014-12-15 | Initiated Coverage | KeyCorp | Hold | |
2014-12-12 | Boost Price Target | Bank of America | Buy | $20.00 to $22.00 |
2014-11-19 | Initiated Coverage | BTIG Research | Buy | $23.00 |
2014-11-10 | Boost Price Target | B. Riley | Neutral | $14.00 to $18.00 |
2014-11-07 | Reiterated Rating | Citigroup Inc. | Neutral | $18.00 to $19.00 |
2014-10-31 | Upgrade | Stifel Nicolaus | Hold to Buy | $20.00 |
2014-10-08 | Upgrade | B. Riley & Co. | Sell to Neutral | $14 to $14 |
2014-10-08 | Upgrade | B. Riley | Sell to Neutral | $14.00 |
2014-09-22 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $18.50 to $20.00 |
2014-09-19 | Downgrade | B. Riley & Co. | Neutral to Sell | |
2014-09-19 | Downgrade | B. Riley | Neutral to Sell | $14.00 |
2014-09-18 | Initiated Coverage | Piper Jaffray | Overweight | $20.00 |
2014-09-02 | Boost Price Target | Citigroup Inc. | Neutral | $16.00 to $18.00 |
2014-08-29 | Reiterated | B. Riley & Co. | Neutral | $16 to $14 |
2014-08-29 | Lower Price Target | Credit Suisse | Neutral | $19.00 to $18.00 |
2014-08-29 | Lower Price Target | B. Riley | Neutral | $16.00 to $14.00 |
2014-08-29 | Lower Price Target | Credit Suisse Group AG | Neutral | $19.00 to $18.00 |
2014-07-16 | Reiterated Rating | Deutsche Bank | Buy | $18.00 to $20.00 |
2014-06-30 | Initiated Coverage | BMO Capital Markets | Outperform | $19.00 |
2014-05-15 | Reiterated Rating | Morgan Stanley | Equal Weight | |
2014-05-15 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $16.00 to $17.00 |
2014-05-15 | Boost Price Target | Credit Suisse | Neutral | $15.00 to $17.00 |
2014-03-12 | Reiterated Rating | Bank of America | Buy | $16.00 to $17.00 |
2014-02-18 | Lower Price Target | Barclays | Equal Weight | $16.00 to $14.00 |
2014-02-06 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | |
2014-02-06 | Upgrade | Wells Fargo | Market Perform to Outperform | |
2014-01-07 | Initiated Coverage | RBC Capital | Sector Perform | $16.00 |
2013-11-19 | Initiated Coverage | Credit Suisse | Neutral | $17.00 |
2013-11-08 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $20.00 to $18.00 |
2013-10-15 | Initiated Coverage | Barclays | Equal Weight | $17.00 |
2013-09-19 | Lower Price Target | B. Riley | Neutral | $19.00 to $17.00 |
2013-09-18 | Reiterated Rating | Citigroup Inc. | Neutral | $17.00 |
2013-09-18 | Reiterated Rating | Deutsche Bank | Buy | $20.00 to $19.00 |
2016-07-09 | Reiterated Rating | Barclays PLC | Hold | |
2016-06-20 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-06-15 | Reiterated Rating | B. Riley | Sell | $19.50 |
2016-05-31 | Reiterated Rating | Deutsche Bank | Buy | |
2016-05-31 | Reiterated Rating | Deutsche Bank AG | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In COTY 228 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 52.31M |
Vanguard Group, Inc | 38.32M |
Clearbridge Investments, LLC | 16.95M |
BlackRock Institutional Trust Company, N.A. | 12.99M |
AMERIPRISE FINANCIAL INC | 11.80M |
SEGALL BRYANT & HAMILL, LLC | 10.36M |
DIMENSIONAL FUND ADVISORS LP | 9.48M |
STATE STREET CORP | 9.27M |
BlackRock Fund Advisors | 7.84M |
Ruffer LLP | 7.45M |
CITADEL ADVISORS LLC | 7.43M |
BNP PARIBAS ARBITRAGE, SA | 7.08M |
Banco Santander, S.A. | 6.32M |
DEUTSCHE BANK AG\ | 5.03M |
VICTORY CAPITAL MANAGEMENT INC | 4.78M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
JAB Cosmetics B.V. | 334.17% (290108041) | COTY / |
HEILBRONN CHARLES | 16.77% (14562993) | COTY / ULTA / |
HARF PETER | 4.54% (3943219) | COTY / |
Becht Lambertus J.H. | 1.21% (1049186) | COTY / |
Schoewel Erhard | 0.43% (371473) | COTY / |
Pane Camillo EVP Category Development | 0.39% (336142) | COTY / |
BLOOM BRADLEY M | 0.34% (297836) | COTY / |
Semerari Renato President of Coty Beauty | 0.30% (259091) | COTY / |
Kleitman Laurent President Coty Consumer Beauty | 0.27% (232000) | COTY / |
Kaufman Jules SVP General Counsel, Secretary | 0.26% (228178) | COTY / IT / |
Mortier Jean President of Coty Prestige | 0.26% (227705) | COTY / |
Faber Joachim | 0.25% (213068) | COTY / |
Lacassagne Geraud-Marie SVP of Human Resources | 0.21% (183718) | COTY / |
Monaco Kevin SVP, Treasurer & IR | 0.20% (176414) | COTY / |
HUBER EDGAR O. President of Coty Luxury | 0.19% (163570) | COTY / LE / |
McMullen Greerson Greene Chief Legal Officer | 0.19% (161725) | COTY / SWM / |
McCall Darryl EVP, Operations | 0.19% (160720) | COTY / |
Singer Robert S | 0.16% (140000) | COTY / MJN / |
Reis Mario EVP, Supply Chain | 0.16% (136000) | COTY / |
Shaefer Peter SVP, Strat. Business Developme | 0.15% (132213) | COTY / |
de Talhouet Patrice Chief Financial Officer | 0.14% (117206) | COTY / |
Froidefond Sebastien SVP of Human Resources | 0.11% (98358) | COTY / |
Moreau Sylvie President, Professional Beauty | 0.11% (97035) | COTY / |
Ramos Daniel E Chief Scientific Officer | 0.08% (69815) | COTY / |
STAHL JACK L | 0.07% (62685) | COTY / CTLT / DPS / |
Macchio Ralph SVP Global Research & Dev.,CSO | 0.07% (59352) | COTY / |
Zafar Ayesha SVP Group Controller | 0.02% (21570) | COTY / |
Muench Thomas SVP, Group Controller | 0.02% (19624) | COTY / |
Pedreiro Sergio Chief Financial Officer | 0.02% (19600) | COTY / |
Goudet Olivier | 0.02% (15000) | COTY / |
Shiah James E. SVP, Chief Acct. & Compl. Off. | 0.01% (11957) | COTY / MJN / |